España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Immunovant
IMVT
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$26.89
0.69
2.61%
At Close: -
$26.89
0
0.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Immunovant (IMVT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Immunovant (NASDAQ:IMVT) Stock
Immunovant Stock (NASDAQ: IMVT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on Im...
Benzinga Newsdesk
Tuesday, June 18, 2024
Cantor Fitzgerald Reiterates Overweight on Im...
Benzinga Newsdesk
Monday, June 03, 2024
Oppenheimer Maintains Outperform on Immunovan...
Benzinga Newsdesk
Thursday, May 30, 2024
Cantor Fitzgerald Reiterates Overweight on Im...
Benzinga Newsdesk
Immunovant shares are trading lower after the...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Immunov...
Benzinga Newsdesk
Wednesday, May 29, 2024
Immunovant shares are trading lower after the...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Immunovant Q4 EPS $(0.52) Misses $(0.43) Esti...
Benzinga Newsdesk
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
Vandana Singh
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Thursday, March 28, 2024
Oppenheimer Initiates Coverage On Immunovant ...
Benzinga Newsdesk
Monday, March 25, 2024
Truist Securities Reiterates Buy on Immunovan...
Benzinga Newsdesk
Thursday, March 21, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, March 13, 2024
Goldman Sachs Initiates Coverage On Immunovan...
Benzinga Newsdesk
Tuesday, March 12, 2024
Immunovant Awarded U.S. Patent for IMVT-1402
Benzinga Newsdesk
Thursday, February 15, 2024
Wolfe Research Initiates Coverage On Immunova...
Benzinga Newsdesk
Monday, February 12, 2024
Recap: Immunovant Q3 Earnings
Benzinga Insights
Immunovant Q3 EPS $(0.36) Up From $(0.49) YoY...
Benzinga Newsdesk
Thursday, December 21, 2023
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
B of A Securities Maintains Buy on Immunovant...
Benzinga Newsdesk
Immunovant shares are trading higher after th...
Benzinga Newsdesk
Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%
Vandana Singh
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Immunova...
Benzinga Newsdesk
Micron Posts Upbeat Sales, Joins Calliditas Therapeutics And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Avi Kapoor
Wednesday, December 20, 2023
Immunovant Says Results From Initial Cohort O...
Benzinga Newsdesk
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Tuesday, December 12, 2023
Immunovant shares are trading higher after De...
Benzinga Newsdesk
Deutsche Bank Initiates Coverage On Immunovan...
Benzinga Newsdesk
Friday, December 01, 2023
Analyst Ratings for Immunovant
Benzinga Insights
UBS Maintains Buy on Immunovant, Raises Price...
Benzinga Newsdesk
Tuesday, November 28, 2023
Roivant Announces Positive IMVT-1402 Initial ...
Benzinga Newsdesk
Wednesday, November 15, 2023
Truist Securities Maintains Buy on Immunovant...
Benzinga Newsdesk
Where Immunovant Stands With Analysts
Benzinga Insights
Truist Securities Maintains Buy on Immunovant...
Benzinga Newsdesk
Thursday, November 09, 2023
Recap: Immunovant Q2 Earnings
Benzinga Insights
Immunovant Q2 EPS $(0.45) Beats $(0.48) Estim...
Benzinga Newsdesk
Tuesday, October 24, 2023
Piper Sandler Maintains Overweight on Immunov...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Immunova...
Benzinga Newsdesk
Monday, October 16, 2023
Cantor Fitzgerald Maintains Overweight on Imm...
Benzinga Newsdesk
Friday, October 13, 2023
Immunovant shares are trading higher after UB...
Bill Haddad
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
Benzinga Insights
UBS Upgrades Immunovant to Buy, Raises Price ...
Benzinga Newsdesk
Monday, October 09, 2023
The Latest Analyst Ratings for Immunovant
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Im...
Benzinga Newsdesk
Thursday, October 05, 2023
Lamb Weston, SP Plus And Other Big Stocks Moving Higher On Thursday
Lisa Levin
Thursday, September 28, 2023
Immunovant Prices $450M Common Share offering...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch